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Abstract
Background: High-risk prescribing in primary care is common and causes considerable harm. Feedback interventions
have small/moderate effects on clinical practice, but few trials explicitly compare different forms of feedback. There is
growing recognition that intervention development should be theory-informed, and that comprehensive reporting
of intervention design is required by potential users of trial findings. The paper describes intervention development
for the Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) study, a pragmatic three-arm cluster
randomised trial in 262 Scottish general practices.
Methods: The NHS chose to implement a feedback intervention to utilise a new resource, new Prescribing Information
System (newPIS). The development phase required selection of high-risk prescribing outcome measures and design
of intervention components: (1) educational material (the usual care comparison), (2) feedback of practice rates of
high-risk prescribing received by both intervention arms and (3) a theory-informed behaviour change component to
be received by one intervention arm. Outcome measures, educational material and feedback design, were developed
with a National Health Service Advisory Group. The behaviour change component was informed by the Theory of
Planned Behaviour and the Health Action Process Approach. A focus group elicitation study and an email Delphi
study with general practitioners (GPs) identified key attitudes and barriers of responding to the prescribing feedback.
Behaviour change techniques were mapped to the psychological constructs, and the content was informed by the
results of the elicitation and Delphi study.
Results: Six high-risk prescribing measures were selected in a consensus process based on importance and feasibility.
Educational material and feedback design were based on current NHS Scotland practice and Advisory Group
recommendations. The behaviour change component was resource constrained in development, mirroring what is
feasible in an NHS context. Four behaviour change interventions were developed and embedded in five quarterly
rounds of feedback targeting attitudes, subjective norms, perceived behavioural control and action planning (2×).
Conclusions: The paper describes a process which is feasible to use in the resource-constrained environment of
NHS-led intervention development and documents the intervention to make its design and implementation explicit
to potential users of the trial findings.
Trial registration: ClinicalTrials.gov: NCT01602705
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Background
Appropriate use of prescription drugs has considerable
benefit to individual patients, but prescription drugs are
also a major cause of avoidable harm [1-3]. Approximately
6.5% of all hospital admissions are caused by adverse drug
events (ADEs), [1] and at least half of these are judged
to be preventable [3]. Reducing primary care high-risk
prescribing is therefore an important issue for health
services. Implementing interventions have been difficult
due to the complexity of defining appropriate measures
of high-risk prescribing and identifying interventions
that are known to be effective.
A number of measures of potentially inappropriate or
high-risk prescribing have been used in research and
service improvement. Examples include indicators from
the Assessing Care of Vulnerable Elders (ACOVE) project,
[4] the Screening Tool of Older Persons’ Potentially in-
appropriate Prescriptions (STOPP), and the Beers Criteria
[5-7]. ACOVE and STOPP rely on manual record review
and are costly to implement on a large scale. The Beers
Criteria can be relatively easily measured using routine
health-care data, but the drugs listed do not include
those most commonly implicated in serious harm. More
recently, new measures of potentially inappropriate pre-
scribing have been defined using consensus methods [8,9]
and have been shown to be both common and highly
variable between practices [10]. Although not all of these
prescriptions will be inappropriate, the high prevalence
and variation indicates that improvement is attainable.
The PINCER trial showed that a complex intervention,
combining pharmacist-facilitated improvement based on
measurement of high-risk prescribing using data held
in practices’ own clinical IT systems, was effective at
reducing targeted prescribing [2]. Potentially, more cost
effective improvement methods have been made possible
by the ongoing development of centrally held patient-level
prescribing datasets. NHS Scotland has implemented an
ePrescribing programme which has created a Scotland-
wide, patient-level prescribing data warehouse (the new
Prescribing Information System (newPIS)), in which ~95%
of prescribed items have a unique patient identifier
attached. This makes it feasible to provide ongoing
feedback on rates of high-risk prescribing to practices. If
shown to be effective, providing feedback of performance
with the aim of improving prescribing safety is an attract-
ive approach because it is easily scalable and relatively
inexpensive, allowing more expensive interventions to
be more selective.
There is evidence that providing feedback can be effect-
ive. At the time of designing the Effective Feedback to
Improve Primary Care Prescribing Safety (EFIPPS) study
in 2010, the most recent Cochrane review (2006) identi-
fied 118 studies of clinical audit and feedback, although
many were small and 80% were methodologically flawed
or weak [11]. The median effect size was a 5% absolute
improvement in binary indicators of guideline compliance,
varying between studies from a 16% absolute worsening to
a 70% absolute improvement. Only a very small number
of studies examined feedback of safety data, mostly relat-
ing to benzodiazepine prescribing in the elderly [11]. The
review identified key gaps in the literature relating to feed-
back, with a need for more theory-informed design [12]
and ‘for head-to-head comparisons of different ways of
doing audit and feedback’ [11]. This review was updated
in 2012 with similar findings, concluding that there is still
a need for future studies of audit and feedback to directly
compare different ways of providing feedback [13].
The need for more theory-informed interventions is
becoming increasingly recognised. New guidelines on
behaviour change recommend the need to ‘specify the
theoretical link between the intervention or programme
and its outcome’ [14]. Key papers on behaviour change
research have been published to help researchers apply
psychological theory in developing interventions and
implementing evidence-based practice [15-17].
The EFIPPS study is a joint academic and NHS initiative
that aimed to develop two theory-informed formats for
prescribing safety feedback, for evaluation of effectiveness
(including cost) compared to simple ‘factual’ educational
material in a large, cluster randomised trial [18]. This paper
describes the development of the intervention which was
intended to be feasible to implement at a large scale, repli-
cated in a resource-constrained NHS context, embedded in
NHS data systems from the outset and informed by both
NHS priorities and behaviour change theory.
Methods
Trial design
This has been described in detail elsewhere, [18] but in
brief, the trial is a pragmatic three-arm cluster rando-
mised trial conducted in general medical practices in
three Scottish Health Boards. General practices are
randomised to one of the three arms, and the research
outcomes (prescribing indicators) will be analysed at
the patient level. This paper describes the initial devel-
opment phase of the study including the selection of
research outcomes and the development and design of
each of the intervention components. The decision to
implement a feedback design was driven by the intention
of the NHS to use a familiar improvement method utilis-
ing the new patient-level prescribing resource, newPIS
and feed back prescribing data to GP practices to enable
them to monitor their own performance.
The components delivered in each arm of the trial are
shown in Figure 1. An Advisory Group was convened
with representatives from the three participating Health
Boards (senior GPs and pharmacists) and the technical
team at NHS Scotland Information Services Division
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who were responsible for creating the feedback from
NHS data. This NHS-led Advisory Group was respon-
sible for selecting high-risk prescribing measures for
feedback and advising on feedback design.
Research outcomes
Outcomes had to be feasible in terms of implementation
in newPIS, and consensus had to be reached among the
Advisory Group as to what was important to NHS
Scotland. Selection of outcomes drew on the findings of
a prior RAND appropriateness method consensus study
involving GPs and primary care pharmacists which
identified candidate indicators [9] and evidence that the
targeted prescribing was reasonably common [10]. Selec-
tion of outcomes for this trial used independent ranking
of a list of candidate outcome measures by the Advisory
Group members followed by in-depth face-to-face group
discussion to reach consensus.
Intervention components
This was a pragmatic trial with an overall aim of design-
ing an intervention that could be feasibly replicated in
a typically resource-constrained NHS context. As well
as being plausibly effective in terms of being likely to
cause a measurable change in prescribing, the interven-
tion had to be developed over a 6-month period with
relatively limited resources, deliverable within the existing
IT systems at NHS Scotland Information Services Division
and be acceptable to all GPs rather than a subset of
research volunteers. The three intervention compo-
nents included (1) educational material received by all
practices (the usual care comparison), (2) feedback of
practice rates of high-risk prescribing received by both
intervention arms and (3) a theory-informed interven-
tion embedded in the feedback received by only one of
the intervention arms.
(1) Educational intervention and support for searching
(same in all three arms). All educational materials
were created by the research team in collaboration
with the Advisory Group and where necessary
topic-specific experts. Support for searching in each
practice’s own IT system was also provided via the
study website which made accessible to a set of
downloadable searches for the general practice
clinical IT systems in use in Scotland.
(2) Feedback of performance on the targeted indicators
(arms two and three only). All practices in the two
treatment arms were sent prescribing feedback, with
arm three additionally receiving the psychology
theory-informed intervention described in the next
section. Based on the data available in newPIS, the
Advisory Group specified that practices should be
emailed five rounds of quarterly written feedback of
their rate of high-risk prescribing to mirror most
prescribing initiatives that are delivered over an
approximate 12-month period (and allowing for a
three-month data lag in the ePrescribing Information
System). Feedback was iteratively designed by the
research team working with the Advisory Group.
Of note is that several of the Advisory Group’s
recommendations are ‘theory-informed’ in the
sense that elements of behaviour change research
evidence have already become ‘normal practice’.
For example, several members of the Advisory
Group emphasised the need for educational material
to provide clear advice on what action to take and the
importance of having a credible messenger in terms
of who signs emails and branding of feedback. These
behaviour change techniques are included in the
extensive list of techniques provided by Michie and
colleagues 2008 [17]. The intention was that the
feedback-only arm of the trial (arm two) should
Cluster randomised trial in 
262 practices in three 
Health Board areas
Arm 1
Educational newsletter
Support for searching
Arm 2
Educational newsletter
Support for searching
+ Feedback of performance
Arm 3
Educational newsletter
Support for searching
+ Feedback of performance
+ Health psychology
informed intervention
Figure 1 Effective feedback to improve primary care prescribing safety trial design.
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represent ‘best practice’ as it would be implemented
by NHS Scotland. The theory-informed intervention
therefore had to implement techniques over and
above those already implemented in ‘normal practice’
to allow proper assessment of the more resource
intensive intervention in arm three.
(3) Theory-informed behaviour change intervention
(arm three only). A number of social cognition
models have been developed to help predict and
understand health behaviours [19]. The Theory of
Planned Behaviour (TPB) is [20] a motivational
model that focuses predominantly on behavioural
intention provided the conceptual framework that
guided the development of the psychology-informed
component of the intervention. TPB is one of the
more commonly used social cognition models and has
been validated and used rigorously in various health
settings [21,22]. While other psychological models of
behaviour change could also have been considered,
TPB was selected for use in the current study due to
both its evidence base and the support available for
health professionals to use this theory should the
trial be rolled out at a national level. To predict
behavioural intentions, TPB focuses on the three
psychological constructs that are amenable to change:
attitude, subjective norms and perceived behavioural
control. A comprehensive TPB manual has been
developed to help researchers construct questionnaires
to measure these constructs that can then be used to
inform intervention design and development [23].
While TPB is predominantly a motivational model to
predict intention, perceived behavioural control is a
determinant of both behavioural intention and
behaviour. A meta-analysis of 87 studies looking at
health behaviours found TPB accounted for 41% of
the variance in intention and 34% of the variance in
behaviour [21]. However, a criticism of TPB and other
motivational models is the implicit assumption
assuming near perfect correspondence between
intention and behaviour, and studies have shown that a
much larger proportion of the variance in intention is
explained compared to that in behaviour [24]. To
address the gap between intention and behaviour, we
also drew on the Health Action Process Approach
(HAPA) [25]. HAPA proposes that the process of
behaviour change can be explained by two distinct
phases: a motivational phase (e.g. social cognition
models such as TPB) and a planning or volitional
phase that focuses on action-controlled strategies.
The volitional phase has three overlapping stages:
planning, action and maintenance, and describes a
post-intention and pre-actionable process that has a
direct correlation with carrying out the action
(or behaviour).
Target behaviours
The TPB manual highlights the importance of defining
the target behaviour in specific terms, although question-
naires using TPB can also be developed to target more
general behaviours [23]. The target behaviour we hoped to
elicit from our intervention was that GPs would ‘respond
to feedback’ by searching in their IT system for patients
receiving a high-risk prescription and reviewing their
prescribing. Due to the nature of the targeted behaviour,
how GPs ‘respond to feedback’ could include a composite
of individual behaviours that vary both by practice and
for individual patients. For example, behaviours carried
out by the GP might include searching for and identify-
ing patients receiving a high-risk prescribing indicator,
reviewing patient records, arranging telephone or face-
to-face consultations and changing patient prescribing
where appropriate. Ultimately, the decision, as to whether
or not a change in medication is required, remains with
the GP since some high-risk prescribing could be appro-
priate in the sense of the benefit outweighing the risks for
a particular individual. Based on pilot work for a different
trial and other published studies, [2,26] the research team
and the Advisory Group strongly believed that reviewing
high-risk prescribing was likely to lead to a change in
medication in a significant proportion of patients. For
this reason, the psychology-informed intervention has
been purposefully targeted at the behaviour of ‘searching
for and reviewing patients with high-risk prescriptions’
with the assumption that this behaviour will be highly
correlated with a change in prescribing (the primary
outcome of the trial is a composite measure of all six
high-risk prescribing indicators).
Elicitation study (focus groups)
An elicitation study consisting of four focus groups, each
comprising between six and ten health professionals was
carried out to develop the measures for the three TPB
psychological constructs (attitude, subjective norms and
perceived behavioural control). Two focus groups were
carried out with GPs: one in Tayside and one in Lothian
(including members of the General Practice Prescribing
Committee) and two with primary care pharmacists: one
in Lothian and one in Tayside. Primary care pharmacists
were invited to take part as they are often involved in
initiatives to change GPs’ prescribing behaviour and
could provide additional insights to those provided by
GPs. Focus groups were facilitated by two members of
the research team (KB, BG). The primary purpose of the
focus groups was to elicit a broad range of attitudes and
potential barriers to carrying out the targeted behaviour,
the results of which would be used to help develop state-
ments relating to the three TPB constructs. For example,
GPs and pharmacists were asked to discuss the advan-
tages and disadvantages of responding to the prescribing
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feedback, the social pressures that GPs might experience
when reviewing high-risk prescribing and changing
medications, the potential barriers or the facilitating
factors of responding to the prescribing feedback.
Email Delphi questionnaire study
A two-stage email Delphi study was conducted with GPs
to prioritise which questionnaire items (or statements)
collated from the elicitation study were the most import-
ant (or influential) to GPs in terms of carrying out the
targeted behaviour, searching for patients in their IT
system and reviewing their prescribing. An invitation
letter to take part in the study, including a participant
information leaflet and a copy of the questionnaire, was
emailed to 500 randomly selected GPs from an email
address list of GPs working in Scotland (excluding GPs
working in the three Health Boards taking part in the
trial). GPs were asked to rate each questionnaire item,
on a five-point Likert scale, their level of agreement
with each statement from strongly agree to strongly
disagree according to their own personal beliefs. Com-
pleted responses were received from 48 GPs (10%
response rate). The 48 GPs who completed the first
questionnaire were then sent the questionnaire a second
time, this time including the median, minimum and max-
imum response scores for each statement received in
round one, and a reminder of how they had personally
scored each item in the first round. GPs were asked to
rescore each statement using the additional knowledge of
their colleagues’ collective response. In round two, 24 of
the 48 GPs responded (50% response rate). Statements
were deemed to be potential candidate variables if a) there
was consensus of positive agreement with the importance
of a statement or b) there was evidence of significant dis-
agreement among the GP responses (>25%; if more than
six GPs were outliers). Questionnaire items were excluded
if there was agreement that a statement was not important
in relation to reviewing patient prescribing (≥75%) or if
more than 50% of GPs gave a neutral response.
The median scores from the questionnaires completed
in round two were then used to identify the questionnaire
items most likely to influence GPs behaviour.
Mapping targeted variables to behaviour change techniques
The next stage was to map the psychology constructs
within each of our two models of behaviour change (TPB,
HAPA) to appropriate behaviour change techniques based
on the evidence as described by Michie and colleagues
[17]. In this paper, Michie and colleagues generated an
extensive list of behaviour change techniques and defini-
tions from techniques published in two systematic reviews,
‘brain storming’ and a systematic search of relevant text-
books. Four experts judged which techniques would be
effective at changing 11 theoretical constructs associated
with behaviour change. The first step in the present study
was to map the four psychological constructs: attitude,
subjective norms, PBC and action planning to the corre-
sponding constructs among the 11 identified by Michie
et al. The next step was to list the techniques where the
experts had reached consensus of ‘agreed use’ or were
‘uncertain’ based on the level of evidence. Techniques
where there was ‘disagreement’ among the experts or
‘agreed non-use’ were not considered.
The feedback intervention in its entirety had been
designed to represent ‘best practice’ and was informed
by an expert Advisory Group. As a result, a number of
the listed techniques were, to varying degrees, already
being utilised in the feedback intervention. Examples of
these included monitoring, feedback, provision of infor-
mation regarding the behaviour/outcome and objects to
facilitate the behaviour (e.g. support for searching in GP
IT systems). The psychology-informed intervention there-
fore had to include techniques that were not already
embedded in the other components of the feedback.
This was in order that any additional effectiveness of
the more resource intensive (in terms of development)
theory-informed intervention could be assessed.
It is also important to note that the choice of techniques
was further constrained by the nature of the trial—the
theory-informed intervention had to be delivered as part
of the quarterly feedback to GP practices and was limited
to one A4 page (a balance between the additional time
cost for GPs engaging with the intervention and encour-
aging behaviour change). The list of behaviour change
techniques is provided in Table 1
Results
Research outcomes
Six prescribing indicators were selected by the Advisory
Group to be targeted by the intervention and measured at
the end of the trial. The selected prescribing indicators are
shown in Table 2.
Intervention components
(1) Educational intervention (same in all three arms).
A two-page written educational intervention was
designed to be delivered to all practices by email in
the month before the trial started. This mirrored
existing prescribing information sent to practices
in overall length and style. The Advisory Group
recommended that it emphasises that high-risk
prescribing is common and that it is good practice
to regularly identify and review patients receiving
high-risk drugs, that it clearly lists the prescribing
indicators targeted, that it summarises the risk that
the targeted prescribing poses and that it provides
clear advice as to what actions to take. A link to an
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NHS Scotland hosted website with additional
information for those who wish to read more is
provided. [see Additional file 1: Short two-page
educational material and Additional file 2:
Supplementary education material available
on the website].
(2) Feedback of performance on the targeted indicators
(arms two and three only). The research team
designed the feedback based on the Advisory Group
specification that feedback should include (1) a clear
statement of its nature (the first page has the title
‘High-risk Prescribing Feedback for Your Practice',
Table 1 TPB constructs and behaviour change techniques
Psychology construct Level of evidence based on expert opinion (Michie [17])
Agreed use Uncertain
Attitude (beliefs about consequences) • Self-monitoring • Monitoring
• Persuasive communication • Graded task
• Information regarding behaviour/outcome • Modelling/demonstration of behaviour
• Feedback
Subjective norms (social influences) • Social processes of encouragement,
pressure, support
• Monitoring
• Modelling/demonstration of behaviours Reward/incentives
• Role play
• Persuasive communication
• Homework
Perceived behavioural control
(beliefs about capabilities and environmental
context and resources)
• Self-Monitoring • Monitoring
• Graded task • Reward/incentives
• Increasing skills, problem solving, goal setting • Stress management
• Coping skills • Information regarding behaviour/outcome
• Rehearsal of relevant skills • Personalised message
• Social processes of encouragement
• Feedback
• Self-talk
• Environmental changes, e.g. objects to facilitate behaviour
Action planning (action planning) • Goal target specified • Monitoring
• Contract • Social processes of encouragement
• Planning/implementation • Personalised message
• Prompts, triggers, cues • Homework
• Use of imagery • Feedback
• Self-talk
Marked in italics demonstrates techniques already incorporated into feedback for both intervention arms two and three.
Marked in bold demonstrates techniques selected and implemented in the psychology-informed intervention.
Table 2 Prescribing indicators selected by the Advisory Group to be used in the trial
Prescribing indicators
1. Oral antipsychotic prescription to a patient aged 75 years and over (as a proxy of oral antipsychotic prescribing to older people with dementia).
2. Oral non-steroidal anti-inflammatory drug (NSAID) prescription to a patient aged 65 years and over who is currently prescribed a diuretic and
an ACE inhibitor or angiotensin receptor blocker (the ‘triple whammy’).
3. Oral NSAID prescription to a patient aged 75 years and over but who is not currently prescribed a gastroprotective drug.
4. Oral NSAID prescription to a patient aged 65 years and over who is currently prescribed either aspirin or clopidogrel but who is not currently
prescribed a gastroprotective drug.
5. Oral NSAID prescription to a patient currently prescribed an oral anticoagulant but who is not currently prescribed a gastroprotective drug.
6. Aspirin or clopidogrel prescription to a patient currently prescribed an oral anticoagulant but who is not currently prescribed a
gastroprotective drug.
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the practice name, a statement of the purpose of
feedback and a list of the indicators); (2) a graphical
summary for each indicator that shows the change
in their practice’s prescribing over time for each
indicator, compared to a national benchmark (which
was set as the lower quartile for all Scottish
practices in the year before the study started, which
was NHS Scotland preferred practice at the time);
(3) a summary of all six indicators on a single page;
(4) a detailed one-page description of each indicator,
consisting of the graphical summary, a statement of
why the indicator matters and what practices should
do, for example, to avoid particular combinations of
drugs or review patients with particular prescribing
(this text is the same for all practices), and an
interpretation of what the graph shows for the
practice receiving the feedback (this text is
automatically generated depending on the data and
is unique to each practice stating, for example, the
number of patients affected in the practice and a
warning about sensitivity of the measure to small
numbers of patients where appropriate) and (5) the
emails sent should be signed by both the Health
Board Medical Director and a named professional
from NHS Scotland Information Services Division
(ISD), and that the feedback should be branded
with Health Board and ISD logos. This is also how
the intervention would be implemented in practice
if it was not part of a research study.
(3) Theory-informed behaviour change intervention
(arm three only). Two psychological models of
behaviour, TPB and HAPA, were selected to inform
an intervention that was designed to target the
behaviour of ‘searching for and reviewing patients
with high-risk prescriptions’ in general practice.
Elicitation study (focus groups)
The focus groups with GPs and pharmacists generated a
broad range of responses regarding the advantages and
disadvantages of responding to the prescribing feedback,
the social pressures that GPs might experience when
reviewing high-risk prescribing and changing medica-
tions, and the potential barriers/or the facilitating factors
of responding to the prescribing feedback. For example,
three out of the four focus groups discussed the attrac-
tion of being able to compare prescribing performance
with other practices as an advantage to taking part in
the intervention and reviewing patient prescribing. The
fear that high-risk prescribing could lead to potential
harm for the practice as well as the patient, particularly
if the prescribing results in a significant event, was also
thought to be an important factor that would encourage
GPs to review patient prescribing. The key disadvantage
that was raised in the focus group discussions was the
impact on GP’s time and work load. The practice
pharmacist and local GP committees were felt to have
the most influence over whether or not GP practices
would endorse the intervention. Patients currently doing
well on their medication and carers/care workers (regard-
ing dementia patients) were thought to the groups most
likely to oppose a change in medication. The key barriers
of responding to the prescribing feedback identified in the
focus groups were if the instructions provided with the
feedback were confusing, there was too much information
or if the message was not in keeping with current advice
from secondary care. The key facilitators of responding to
the prescribing feedback were if GPs believed that the
feedback was important and clearly branded, could be
delivered face-to-face e.g. via the practice pharmacist and
if the feedback was related to research and improving
patient safety rather than cost-effectiveness.
Email Delphi questionnaire study
The broad ranges of responses obtained in the focus
groups were transcribed into statements corresponding
to the three TPB constructs. For example:
 Attitude—If I respond to prescribing feedback I will
feel like I am doing something positive for the patient.
 Subjective norms—Approval from other GPs in my
Practice is important to me.
 Perceived behavioural control—It would be difficult
for me to respond to prescribing feedback due to
limited practice resources.
A total of 59 statements were collated and included in
the Delphi questionnaire. Twenty-four GPs from various
Scottish Health Boards completed both rounds of the
Delphi questionnaire, scoring each statement in terms of
their own beliefs of the importance or influence of the
statement on the targeted behaviour: responding to feed-
back by searching for patients in their IT system and
reviewing their prescribed medications. Consensus was
reached on 50 of the 59 statements, only two statements
received a neutral response where more than 50% of re-
spondents neither agreed nor disagreed with the import-
ance of the statement, and consensus was not met for
seven of the 59 statements. A summary of the statements
that reached consensus and those where there was dis-
agreement are shown in Table 3. Neutral responses were
received for two statements whether the pharmaceutical
industry had an influence on a GP’s decision to review
patient prescribing and whether approval from the
press was important to GPs.
Mapping targeted variables to behaviour change techniques
The research team selected behaviour change techniques
from an evidence-based list, [17] for each of the four
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constructs within the two psychological models that had
been selected to inform the intervention: attitude, sub-
jective norms, perceived behavioural control and action
planning. The Advisory Group recommended that the
psychology-informed intervention should be different for
each round of feedback since they believed that this
would maximise the potential of it to change behaviour.
It was evident from the elicitation study that the behav-
iour sequence that practices would engage in to ‘respond
to the prescribing feedback’ would vary across practices.
Of note is that the pragmatic nature of the delivery of
the feedback meant that the intervention would first be
sent to the practice managers’ who would then choose
how to disseminate the information to the GPs. This
reflects how such feedback would be implemented in
the ‘real world’ but makes it harder to identify ‘specific’
behaviours to target. Results from the Delphi study con-
firmed that the core attitudes, social norms, barriers and
facilitating factors of responding to the prescribing feed-
back were consistent. For this reason, the research team
Table 3 Summary table of the key results from the Delphi questionnaire
TPB constructs Delphi questionnaire: results
Attitude Consensus of agreement regarding ATTITUDES toward responding to prescribing feedback
(≥75% agree/strongly agree; ≥6 GPs were outliers)
Reviewing patient prescribing was a positive thing to do for the patient.
Reviewing patient prescribing gave GPs a sense of protecting their patients.
The fear of a patient having a significant event as a result of receiving high-risk prescribing caused GPs concern.
Reviewing patient prescribing was important.
GPs do not regard receiving prescribing feedback as a criticism.
GPs would not feel defensive in response to receiving prescribing feedback.
There was disagreement among GP responses to the following statements (>25%; more than 6 GPs were outliers)
Being seen by my colleagues to have unwittingly prescribed a high-risk drug would be embarrassing.
A negative event as a result of changing prescribing in the past would make me less likely to change or stop
medications in the future.
Subjective norms Consensus of agreement regarding the importance of other groups and the importance of their opinions to GPs
(≥75% agree/strongly agree)
The groups of people most likely to approve of responding to prescribing feedback were the GMC, other GPs
and practice pharmacists.
Approval from patients and GPs within their own practice was most important, followed by approval from the
GMC then the practice pharmacist.
Perceived Behavioural
Control (PCB)
Consensus of agreement regarding the BARRIERS to respond to the prescribing feedback (≥75% agree/strongly agree)
GPs would be less likely to respond to the prescribing feedback if clinical guidelines are unclear, or there is no
sound evidence base.
A negative event as a result of changing prescribing in the past would make GPs less likely to change or stop
patient’s medication in the future.
There was disagreement among GP responses to the following statements (>25%)
I already have too much to do and would struggle to find time to review patients receiving high-risk prescribing.
I will not respond to the prescribing feedback if it appears difficult, or it is not clear what I need to do.
Even when it is high risk, I find it difficult to change my patients prescribing when they feel fine and are having
little or no side effects from their medication.
I find stopping medications more difficult if the medication was started in secondary care.
Patient preferences are a key determinant for me when considering whether or not to change a patient’s medication.
Consensus of agreement regarding FACILITATORS of responding to the prescribing feedback
(≥75% agree/strongly agree)
Prescribing feedback is more persuasive if the recommendations are in line with SIGN/NICE guidelines.
The messenger is important, and GPs would be more likely to respond to the prescribing feedback that came from
the practice pharmacist, a respected clinician or the Health Board.
GPs would be more likely to respond to the prescribing feedback knowing that they would be able to benchmark
the performance of their practice against other practices.
GPs would be more likely to respond to the prescribing feedback if they could use the reviews as part of their
annual appraisal.
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chose to design a behaviour change intervention for each
of the four psychology constructs within the two models:
attitudes (TPB), subjective norms (TPB), perceived be-
havioural control (TPB) and action planning (HAPA).
The results from the email Delphi questionnaire were
used to inform the content and design of each of the
four A4 page interventions. The psychology-informed
interventions are available to view as Additional file 3:
Psychology-informed interventions.
Participating practices in arm three would receive inter-
ventions targeting (in order of receipt): action planning
(HAPA), perceived behavioural control (TPB), attitude
(TPB), subjective norms (TPB) and a repeat of the action
planning intervention in the fifth round of feedback.
The intervention appears as page two in the feedback
document. An example of the feedback document is
available to view as Additional file 4: Example feedback
intervention.
Discussion
The aim of this paper was to describe in detail the
design and development of a feedback intervention for
a cluster randomised trial evaluating the impact on
high-risk prescribing of two different designs of feed-
back compared to a simple educational message. The
results of the previous clinical audit feedback trials have
been mixed [11], and in terms of evaluation, a major
criticism has been that most have not been informed by
theory or been explicit in their approach [12].
This study provides an unusual opportunity to provide
a practical demonstration of how one might use theory
to inform an intervention, given real-life constraints, and
rigorously test the intervention in a health-care setting.
This was a pragmatic trial, which was intended to be
feasible to implement at a large scale by virtue of being
embedded in NHS data systems from the outset, and was
therefore limited by time, cost and practical constraints.
While we acknowledge that a more sophisticated and
costly psychology-informed intervention might plausibly
produce a larger effect size, we sought to test whether
investing in a ‘real-world’ feasible resource, to develop a
theory-informed intervention, improved prescribing more
than the development of a current ‘best practice’ form
of feedback. Drawing on the behaviour change litera-
ture, we selected evidence-based theories to inform our
intervention for changing prescribing behaviour. The
development of our elicitation study and Delphi ques-
tionnaire was informed by TPB where we referred to
the TPB manual, designed specifically to help health
services researchers, use behaviour change theory to
design and develop questionnaires, the results of which
can then be used to help inform targeted interventions. In
terms of reporting, we have been guided by the Consoli-
dated Standards of Reporting Trials (CONSORT) group
[27] and the recommendations of Michie et al. [28] and
the recent introduction of the Workgroup for Interven-
tion Development and Evaluation Research (WIDER) [29].
Conclusions
A criticism of previous published behaviour change inter-
vention studies has been that they have lacked explicit
detail in their approach and therefore hinder their repro-
ducibility [30]. Our aims in this paper were to describe in
detail the design and development of our feedback inter-
vention and to provide a pragmatic ‘real-life’ example of
implementing a theory-informed intervention. We believe
that documenting the intervention in detail is important in
supporting the interpretation of the findings of the main
trial and will make a useful contribution to the literature on
intervention development, particularly for researchers or
health service improvement professionals working within
the constraints of a real-life health-care setting.
Additional files
Additional file 1: Short two-page educational material. This file contains
the education material that was delivered to all three arms of the trial.
Additional file 2: Supplementary educational material available on
the website. This file contains the supplementary educational information
that was available to all three arms of the trial via the website. Practices
were directed to the website, and the supplementary information, in the
short educational material that was delivered to all practices.
Additional file 3: Psychology-informed interventions. This file
contains each of the four one-page psychology informed interventions
that were embedded in each of the five quarterly rounds of feedback.
Action planning was repeated in the fifth round of feedback.
Additional file 4: Example feedback intervention (arm three). This
file contains an example of one round of quarterly feedback delivered to
a practice in arm three of the trial.
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